Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Aratana Therapeutics, Inc.

NASDAQ: PETXHealthcare / Biotechnology / USA
3.71+0.0500+1.37%Vol 8 4421Y Perf -9.18%
Mar 18th, 2019 09:37
BID3.67 ASK3.73
Open3.64 Previous Close3.80
Pre-Market- After-Trading3.66
 - -%  - -%
Target Price
7.33 
Analyst Rating
Moderate Buy 2.33
Potencial %
97.04 
Finscreener Ranking
★★★+     53.80
Insiders Trans % 3/6/12M
-100/-100/-100 
Value Ranking
★★     46.80
Insiders Value % 3/6/12M
-100/-100/-100 
Growth Ranking
★★★+     54.87
Insiders Shares Cnt. % 3/6/12M
-100/-100/-100 
Income Ranking
 —    -
Market Cap (mil)180 
Earnings Rating
Strong Buy
Price Range Ratio 52wk %
10.62 
Earnings Date
2nd May 2019

Today's Price Range

3.643.76

 

52wk Range

3.307.16

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Month
-17.19%
3 Months
-40.49%
6 Months
-31.46%
1 Year
-9.18%
3 Years
-12.44%
5 Years
-78.51%

Name / TickerPriceChg.Chg.%
PETX3.710.05001.37
AAPL186.670.55000.30
GOOG1 180.02-4.4400-0.37
MSFT116.580.67000.58
XOM80.660.51000.64
WFC51.220.56001.11
JNJ136.94-0.6600-0.48
FB162.39-3.5900-2.16
GE10.030.07000.70
JPM106.850.30000.28
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
2.60
Current Ratio
3.20
Long Term Debt to Total Capital
0.02
Total Debt to Equity
0.23
Interest Coverage
-5.70
Leverage Ratio 1.40
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
66.60
EBIT Margin
-45.00
EBITDA Margin
-42.70
Pre-tax Profit Margin
-3 671.10
Profit Margin
-19.96
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)
30 506
Revenue per Share
0.63
Revenue Growth 3 Years
221.14
Revenue Growth 5 Years
231.26

Earnings HistoryEstimateReportedSurprise %
Q04 2018-0.11-0.18-63.64
Q03 2018-0.130.19246.15
Q02 2018-0.19-0.1426.32
Q01 2018-0.18-0.19-5.56
Q04 2017-0.23-0.1917.39
Q03 2017-0.26-0.2119.23
Q02 2017-0.29-0.2610.34
Q01 2017-0.34-0.340.00
Earnings Per EndEstimateRevision %Trend
12/2018 QR-0.120.00-
12/2018 FY-0.26-4.00Negative
3/2019 QR-0.11-37.50Negative
12/2019 FY-0.28-27.27Negative
Next Report Date2nd May 2019
Estimated EPS Next Report-0.10
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume8 442
Shares Outstanding (in ths.)48 624
Trades Count5
Dollar Volume7 131
Avg. Volume704 778
Avg. Weekly Volume598 820
Avg. Monthly Volume356 315
Avg. Quarterly Volume653 277

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

50%50%

Bearish Bullish

60%40%

Bearish Bullish

61%39%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
1 (33.33 %)
1 (25.00 %)
3 (75.00 %)
Moderate Buy
0 (0.00 %)
1 (25.00 %)
1 (25.00 %)
Hold
2 (66.67 %)
2 (50.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingModerate Buy
2.33
Moderate Buy
2.25
Strong Buy
1.25

There are no comments yet.

News